New strategy aims to boost COVID-19 shots in pregnancy

NCT ID NCT05570630

Completed Prevention Sponsor: University of Rochester Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This completed trial tested a program to increase COVID-19 vaccination among pregnant women. Over 6,900 participants were involved across OB/GYN practices. The program included training for healthcare providers, reminders, and feedback on vaccination rates. The goal was to see if these steps could raise vaccination rates and protect more mothers and babies from severe COVID-19.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (training, prompts, standing orders, feedback)
What this could lead to: If successful, this approach could help more pregnant people get vaccinated against COVID-19, reducing severe illness and pregnancy complications.
What could go wrong: The trial is already completed, but results may not apply to all populations or future variants. The intervention only targets vaccination rates, not vaccine efficacy or safety.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Infections infectious disease pregnancy disorder COVID-19 prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

COVID-19 IMMUNIZATION; INFECTION PREGNANCY RELATED

Contacts and locations

Locations

University of Rochester Medical Center (URMC)

Rochester, New York, 14642, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.